Confirmation of improved local-regional control with altered fractionation in head and neck cancer.

[1]  E. Zubizarreta,et al.  Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer , 2000, International journal of cancer.

[2]  J. Bourhis,et al.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.

[3]  K. Ang,et al.  Altered fractionation trials in head and neck cancer. , 1998, Seminars in radiation oncology.

[4]  J H Hendry,et al.  A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. , 1998, International journal of radiation oncology, biology, physics.

[5]  J. Horiot,et al.  Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  S Schraub,et al.  Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  W. Curran,et al.  Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report. , 1991, International journal of radiation oncology, biology, physics.

[8]  C. C. Wang,et al.  Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. , 1988, International journal of radiation oncology, biology, physics.

[9]  S. Tucker,et al.  Isoeffect models and fractionated radiation therapy. , 1987, International journal of radiation oncology, biology, physics.